HonorHealth Scottsdale Shea Medical Center Builds Advanced Robotic Program to Treat Heart Rhythm Disorders
25. Januar 2022 09:07 ET
|
Stereotaxis, Inc.
ST. LOUIS, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that HonorHealth has...
Stereotaxis Robotic Technology Reduces Incidence of Silent Cerebral Embolism During Atrial Fibrillation Ablation in New Peer-Reviewed Publication
08. Dezember 2021 08:03 ET
|
Stereotaxis, Inc.
ST. LOUIS, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in...
Stereotaxis to Host Inaugural Innovation Day – Pioneering Endovascular Robotics
18. November 2021 08:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it will host...
BJC HealthCare Becomes First Health Care System in Midwest to Adopt Latest Robotic Technology for Arrhythmia Treatment
15. November 2021 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces today that BJC...
Stereotaxis Reports 2021 Third Quarter Financial Results
11. November 2021 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today reported financial results...
Stereotaxis Technology, Clinical Value and Innovations to be Highlighted at Society for Cardiac Robotic Navigation Meeting
08. November 2021 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announces it will attend...
Stereotaxis to Report Third Quarter 2021 Financial Results on November 11, 2021
28. Oktober 2021 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will...
First Patients Treated in Southern Europe with Stereotaxis Genesis Robotic Technology
18. Oktober 2021 07:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced installation of...
International Journal of Cardiology Publishes Data Demonstrating Superior Outcomes of Stereotaxis Robotic Cardiac Ablation in Pediatric Patients
12. Oktober 2021 07:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in...
Stereotaxis to Present at Upcoming Investor Conferences
09. September 2021 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David...